NASDAQ:ACRS – Knox Daily

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Aclaris Therapeutics Inc’s recent filing unveils that its Director Mehra Anand acquired Company’s shares for reported $1.5 million on Nov

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Aclaris Therapeutics

Insiders Updates

Aclaris Therapeutics Inc’s recent filing unveils that its Director Mehra Anand acquired Company’s shares for reported $1.5 million on Nov

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

Aclaris Therapeutics Inc’s filing revealed that its Director Mehra Anand acquired Company’s shares for reported $1.5 million on Nov 19

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Aclaris Therapeutics Inc’s recent filing unveils that its Director Mehra Anand acquired Company’s shares for reported $1.5 million on Nov

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Aclaris Therapeutics Inc’s recent filing unveils that its 10% Owner Leonard Braden Michael acquired Company’s shares for reported $0.26 million

Tag: NASDAQ:ACRS